MetaCap

NovoCure (NVCR) News

NASDAQ: NVCRHealth CareMedical/Dental InstrumentsUSD

10.71+0.02 (+0.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NVCR news summary

We found 11 recent headlines mentioning NovoCure (NVCR): 0 in the past week and 11 in the past 30 days, most often from Nasdaq, Seeking Alpha, Business Wire. For price context, NVCR is up 0.19% at $10.71. The most recent story, "FDA Rejects NovoCure’s Optune Mya for Lung Cancer Brain Metastases. Here's What It Means for Investors.", was published by Nasdaq on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest NovoCure headlines

Stocks mentioned alongside NVCR

Compare NVCR